Panel Discussion: Hearing Korean ADC Developers’ Perspectives on ADC Development to Accelerate Innovation & Establish South Korea as a Hub of ADC Development

• Honing insights from ADC pioneers in South Korea on cutting-edge research and lessons learned that are driving innovations
• Understanding how partnerships with pharma are accelerating ADC development
• Analyzing the future direction of ADC development to strengthen Korea’s global leadership in next-generation ADC therapeutics

Speakers:

Nam-Gu Her

Chief Executive Officer

Aimed Bio Inc.

Doo Young Jung

Founder & Chief Executive Officer

Pinot Bio

Joseph Kim

Senior Vice President

Kanaph Therapeutics

Chul Woong Chung

Chief Technology Officer

LigaChem Biosciences